A novel detection method of non-small cell lung cancer using multiplexed bead-based serum biomarker profiling.

[1]  E. Gabazza,et al.  Evaluating prethrombotic state in lung cancer using molecular markers. , 1993, Chest.

[2]  Kikuya Kato.  Algorithm for in vitro diagnostic multivariate index assay , 2009, Breast cancer.

[3]  R Doll,et al.  Mortality from smoking worldwide. , 1996, British medical bulletin.

[4]  Leo Breiman,et al.  Random Forests , 2001, Machine Learning.

[5]  Pil Je Park,et al.  The multiplex bead array approach to identifying serum biomarkers associated with breast cancer , 2009, Breast Cancer Research.

[6]  N. Zandwijk.  New methods for early diagnosis of lung cancer. , 2002 .

[7]  L. Chouchane,et al.  Proteomics-based identification of alpha1-antitrypsin and haptoglobin precursors as novel serum markers in infiltrating ductal breast carcinomas. , 2009, Clinica chimica acta; international journal of clinical chemistry.

[8]  M Paesmans,et al.  CYFRA 21-1 is a prognostic determinant in non-small-cell lung cancer: results of a meta-analysis in 2063 patients , 2004, British Journal of Cancer.

[9]  E. Tabakoğlu,et al.  High plasma D-dimer level is associated with decreased survival in patients with lung cancer. , 2007, Clinical oncology (Royal College of Radiologists (Great Britain)).

[10]  M Soledad Cepeda,et al.  Comparison of logistic regression versus propensity score when the number of events is low and there are multiple confounders. , 2003, American journal of epidemiology.

[11]  J. Tarrant,et al.  Blood Cytokines as Biomarkers of In Vivo Toxicity in Preclinical Safety Assessment: Considerations for Their Use , 2010, Toxicological sciences : an official journal of the Society of Toxicology.

[12]  Faina Linkov,et al.  Early Detection of Head and Neck Cancer: Development of a Novel Screening Tool Using Multiplexed Immunobead-Based Biomarker Profiling , 2007, Cancer Epidemiology Biomarkers & Prevention.

[13]  Xiangning Fu,et al.  [The changes of blood coagulation in surgical patients with lung cancer]. , 2010, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

[14]  Keith M. Kerr,et al.  Gene Expression Profiling in Non-Small Cell Lung Cancer , 2004, Clinical Cancer Research.

[15]  E. Baker,et al.  Profiles of inflammatory cytokines following colorectal surgery: Relationship with wound healing and outcome , 2006, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[16]  M. Schietroma,et al.  Changes in the blood coagulation, fibrinolysis, and cytokine profile during laparoscopic and open cholecystectomy , 2004, Surgical Endoscopy And Other Interventional Techniques.

[17]  N. Lai,et al.  CYFRA 21-1 enzyme-linked immunosorbent assay. Evaluation as a tumor marker in non-small cell lung cancer. , 1996, Chest.

[18]  Domenico Coppola,et al.  Expression and distribution of insulin-like growth factor-1 receptor in human carcinomas. , 2003, Human pathology.

[19]  K. Lunetta,et al.  Identifying SNPs predictive of phenotype using random forests , 2005, Genetic epidemiology.

[20]  William L. Bigbee,et al.  Multiplexed Immunobead-Based Cytokine Profiling for Early Detection of Ovarian Cancer , 2005, Cancer Epidemiology Biomarkers & Prevention.

[21]  A. Agadir,et al.  Cytometric bead array: a multiplexed assay platform with applications in various areas of biology. , 2004, Clinical immunology.

[22]  H. Suzuki,et al.  Elevated plasma levels of interleukin-6, interleukin-8, and granulocyte colony-stimulating factor during and after major abdominal surgery. , 1997, Journal of clinical anesthesia.

[23]  D. Vignali.  Multiplexed particle-based flow cytometric assays. , 2000, Journal of immunological methods.